Finance

Lists
2070:TADAWUL
Saudi Pht Ind nd Mdl Apl Crp SPM ADW SJS
SAR 30.10
-1.18%
(-0.36) 1D
Oct 15, 3:10:27 PM GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 2070...
Open
SAR 30.30
High
SAR 30.32
Low
SAR 29.72
Mkt. cap
3.61B
Avg. vol.
766.39K
Volume
454.51K
Dividend
1.16%
Quarterly dividend
SAR 0.09
Ex-dividend date
Jun 10, 2026
P/E ratio
16.76
52-wk high
SAR 33.32
52-wk low
SAR 24.96
EPS
SAR 1.80
Shares outstanding
119.28M
Open
SAR 30.30
High
SAR 30.32
Low
SAR 29.72
Mkt. cap
3.61B
Avg. vol.
766.39K
Volume
454.51K
Dividend
1.16%
Quarterly dividend
SAR 0.09
Ex-dividend date
Jun 10, 2026
P/E ratio
16.76
52-wk high
SAR 33.32
52-wk low
SAR 24.96
EPS
SAR 1.80
Shares outstanding
119.28M
News stories
From web sources and news partners
About Saudi Pht Ind nd Mdl Apl Crp SPM ADW SJS
CEO-
Employees-
FoundedJan 20, 1986
Headquarters-
SectorPharmaceutical industry
Websitespimaco.com.sa
Previous reportsAll values in SAR
Loading Previous Earnings...
Revenue
Net income
All values in SAR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
415.30M
405.80M
423.83M
492.86M
Cost of goods sold
212.39M
211.04M
187.72M
252.78M
Cost of revenue
212.39M
211.04M
187.72M
252.78M
Research and development expenses
13.76M
18.78M
11.12M
12.71M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
132.63M
123.88M
122.08M
136.39M
Operating expense
129.53M
194.27M
145.62M
153.68M
Total operating expenses
341.92M
405.31M
333.34M
406.46M
Operating income
73.38M
498.00K
90.49M
86.40M
Other non operating income
-
-
-
-
EBT including unusual items
50.12M
36.97M
77.81M
77.50M
EBT excluding unusual items
57.11M
-6.74M
78.34M
76.42M
Income tax expense
6.54M
-5.14M
9.66M
7.64M
Effective tax rate
13.04%
-13.92%
12.42%
9.86%
Other operating expenses
-16.86M
30.30M
-6.90M
-1.06M
Net income
42.14M
38.77M
65.07M
68.41M
Net profit margin
10.15%
9.55%
15.35%
13.88%
Earnings per share
-
-
-
-
Interest and investment income
2.60M
4.88M
2.74M
2.63M
Interest expense
-23.23M
-16.55M
-19.69M
-20.40M
Net interest expenses
-20.63M
-11.68M
-16.95M
-17.77M
Depreciation and amortization charges
-
-
-
-
EBITDA
103.80M
20.20M
112.91M
109.23M
Gain or loss from assets sale
-10.92M
716.00K
276.00K
67.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps